Showing 20 of 117 recruiting trials for “acute-myeloid-leukemia-with-t816p11p13-translocation”
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
A Single-arm, Prospective Study of a Cladribine-Bridged LABU Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory MDS/AML in Elderly Patients
👨⚕️ Depei Wu, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Apr 2026View details ↗
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
👨⚕️ Anna Halpern, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Oct 2025View details ↗
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
👨⚕️ Naveed Ali, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Sep 2025View details ↗
Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
👨⚕️ Thomas Knight, MD, Wake Forest University Health Sciences📍 2 sites📅 Started Jun 2025View details ↗
VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
👨⚕️ Roni Tamari, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Jun 2025View details ↗
A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
👨⚕️ Mendel Goldfinger, MD, Montefiore/Einstein Cancer Center📍 1 site📅 Started Jun 2025View details ↗
Page 1 of 6Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →